my account  log out
 

Male Enhancement Nolvadex 54965-24-1 Bulking Cycle Steroids Powder Tamoxifen Citrate 99%

Create: 08/30/2016
Expired Date:08/31/2018
Category: Methacrylate intermediates [Chemical]
Message:Male Enhancement Nolvadex 54965-24-1 Bulking Cycle Steroids Powder Tamoxifen Citrate 99% Key words:tamofen,Tamoxifen citrate,Tamoxifen citrate,Tamoxifen,Tamoxifen,Nolvadex,Nolvadex,Anti-estrogen Steroids,steroid powder,hormone raw powder,tamofen,tamofen USE: Anti tumor drug Chemical Name: (Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxyl]-N,N-dimethyl-ethanamine-citrate; 1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene citrate Molecular Formula: C26H29NO.C6H8O7 Molecular weight: 563.64 CAS NO.: 54965-24-1 Appearance: white crystalline powder MP: 140-144 ºC Applications: 1. Nolvadex is not an anabolic steroid but is used to manage side effects from steroids. 2. Nolvadex is a mixed estrogen agonist/antagonist of the same type as Clomid. 3. Tamoxifen Citrate is the raw material of Nolvadex. 4. Nolvadex is also a kind of medicine to treat cancer. 5. Nolvadex (tamoxifen citrate) is very comparable to Clomid. 6. Nolvadex behaves in the same manner in all tissues with Clomid. For the treatment of advanced, recurrent breast cancer and ovarian cancer and other illnesses. Used as an antineoplastic raw materials. Biological Activity: Estrogen receptor antagonist/partial agonist. Selective and potent inhibitor of mammalian sterol isomerase. Neuroprotective in female rats in vivo . Also high affinity agonist at the membrane estrogen receptor GPR30. cindy1114 (at)ycccreate (dot)com
City:Wuhan[CN] 
Location:
 
Aug 31 2016 Tert-Butylhydrazine hydrochloride484
Aug 31 2016 2,4-Dichlorophenol505
Aug 31 2016Maduramycin Ammonium465
Aug 31 2016Albendazole494
Aug 31 2016 Orgotein502
Aug 31 2016(-)-Epigallocatechin gallate499
Aug 31 2016 Naftalofos479
Aug 31 2016 Febantel484
Aug 31 2016 Benzyldodecyldimethylammonium bromide495
Aug 31 2016 Cephapirin Benzathine497

return back

Copyright © toextrade Inc. All rights reserved. Contact us